Curis (CRIS) Receivables (2010 - 2025)

Curis (CRIS) reported Receivables of $3.2 million for Q3 2025, up 8.9% on a YoY basis from $3.0 million in Q3 2024, and up 17.84% quarter-over-quarter from $2.8 million in Q2 2025.

Curis (CRIS) Receivables (2010 - 2025) Analysis & Trends

Curis has reported Receivables for 16 years, with the latest figure at $3.2 million in Q3 2025.

  • For the quarter ending Q3 2025, Receivables rose 8.9% year-over-year to $3.2 million; the trailing twelve-month figure through Sep 2025 stood at $3.2 million (up 8.9% YoY), and the FY2024 full-year result was $3.3 million, up 19.86% from the prior year.
  • Receivables for Q3 2025 stood at $3.2 million, up from $2.8 million in the prior quarter.
  • The five-year high for Receivables was $3.3 million in Q4 2024, with the low at $2.1 million in Q1 2022.
  • Historically, Receivables has averaged $2.7 million across 5 years, with a median of $2.8 million in 2025.
  • Annual changes were most pronounced in 2021 — Receivables slipped 12.92% — and 2024, when it climbed 19.86%.
  • Curis' Receivables stood at $3.2 million in 2021, then dropped by 7.72% to $3.0 million in 2022, then dropped by 6.08% to $2.8 million in 2023, then climbed by 19.86% to $3.3 million in 2024, then dropped by 3.17% to $3.2 million in 2025.
  • The last three Receivables figures came in at $3.2 million (Q3 2025), $2.8 million (Q2 2025), and $2.3 million (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 13.10 Mn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - -
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 2.00 Bn
9 Abivax 95.45 Bn 95.45 Bn - -
10 Curis 8.58 Mn -6.42 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 3.24 Mn
Jun 30, 2025 2.75 Mn
Mar 31, 2025 2.32 Mn
Dec 31, 2024 3.35 Mn
Sep 30, 2024 2.98 Mn
Jun 30, 2024 2.55 Mn
Mar 31, 2024 2.15 Mn
Dec 31, 2023 2.79 Mn
Sep 30, 2023 2.85 Mn
Jun 30, 2023 2.39 Mn
Mar 31, 2023 2.31 Mn
Dec 31, 2022 2.98 Mn
Sep 30, 2022 2.89 Mn
Jun 30, 2022 2.40 Mn
Mar 31, 2022 2.06 Mn
Dec 31, 2021 3.22 Mn
Sep 30, 2021 2.96 Mn
Jun 30, 2021 2.38 Mn
Mar 31, 2021 2.18 Mn
Dec 31, 2020 3.04 Mn